BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 4, 2026
Home
»
Topics
»
Infection
» HIV/AIDS
HIV/AIDS
RSS
GlaxoSmithKline and Pfizer enter agreement to create a new HIV company
April 17, 2009
Tobira Therapeutics initiates proof-of-concept study with TAK-652 for HIV
April 15, 2009
Phase II study reveals activity of OZ1 gene therapy in HIV patients
April 15, 2009
Health Canada approves once-daily Prezista as part of combination HIV therapy
April 8, 2009
Spaltudaq changes name to Theraclone and reports results from HIV antibody study
April 1, 2009
Novel amide ketoacid-based inhibitors of HIV integrase show oral antiviral activity
April 1, 2009
Avexa reaches 16-week evaluation point in phase III trial of apricitabine in HIV
March 25, 2009
New cytochrome P450 inhibitors for HIV infections claimed by Gilead
March 18, 2009
Avexa reports 96-week data from phase IIb apricitabine trial in HIV
March 17, 2009
Novel non-nucleoside reverse transcriptase inhibitors claimed by GlaxoSmithKline
March 11, 2009
Previous
1
2
…
126
127
128
129
130
131
132
133
134
…
423
424
Next
RSS